Puma Biotechnology (PBYI) PT Raised to $9 at Goldman Sachs
Get Alerts PBYI Hot Sheet
Price: $8.53 --0%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 39
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 39
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi raised the price target on Puma Biotechnology (NASDAQ: PBYI) to $9.00 (from $8.00) while maintaining a Sell rating.
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Saab AB (SAABB:SS) (SAABF) to Hold
- Epiroc AB (EPIA:SS) (EPOKY) PT Lowered to SEK295 at Kepler Cheuvreux
- Evolution AB (EVO:SS) (EVGGF) PT Raised to SEK830 at Kepler Cheuvreux
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share